Global Drugs for Malaria Supply, Demand and Key Producers, 2026-2032
The global Drugs for Malaria market size is expected to reach $ million by 2032, rising at a market growth of %CAGR during the forecast period (2026-2032).
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.
This report studies the global Drugs for Malaria demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs for Malaria, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Malaria that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drugs for Malaria total market, 2021-2032, (USD Million)
Global Drugs for Malaria total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Drugs for Malaria total market, key domestic companies, and share, (USD Million)
Global Drugs for Malaria revenue by player, revenue and market share 2021-2026, (USD Million)
Global Drugs for Malaria total market by Type, CAGR, 2021-2032, (USD Million)
Global Drugs for Malaria total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Drugs for Malaria market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Drugs for Malaria market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drugs for Malaria Market, By Region:
1. How big is the global Drugs for Malaria market?
2. What is the demand of the global Drugs for Malaria market?
3. What is the year over year growth of the global Drugs for Malaria market?
4. What is the total value of the global Drugs for Malaria market?
5. Who are the Major Players in the global Drugs for Malaria market?
6. What are the growth factors driving the market demand?
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.
This report studies the global Drugs for Malaria demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs for Malaria, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Malaria that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drugs for Malaria total market, 2021-2032, (USD Million)
Global Drugs for Malaria total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Drugs for Malaria total market, key domestic companies, and share, (USD Million)
Global Drugs for Malaria revenue by player, revenue and market share 2021-2026, (USD Million)
Global Drugs for Malaria total market by Type, CAGR, 2021-2032, (USD Million)
Global Drugs for Malaria total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Drugs for Malaria market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Drugs for Malaria market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drugs for Malaria Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Others
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
1. How big is the global Drugs for Malaria market?
2. What is the demand of the global Drugs for Malaria market?
3. What is the year over year growth of the global Drugs for Malaria market?
4. What is the total value of the global Drugs for Malaria market?
5. Who are the Major Players in the global Drugs for Malaria market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drugs for Malaria Introduction
1.2 World Drugs for Malaria Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Drugs for Malaria Total Market by Region (by Headquarter Location)
1.3.1 World Drugs for Malaria Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Drugs for Malaria Revenue (2021-2032)
1.3.3 China Based Company Drugs for Malaria Revenue (2021-2032)
1.3.4 Europe Based Company Drugs for Malaria Revenue (2021-2032)
1.3.5 Japan Based Company Drugs for Malaria Revenue (2021-2032)
1.3.6 South Korea Based Company Drugs for Malaria Revenue (2021-2032)
1.3.7 ASEAN Based Company Drugs for Malaria Revenue (2021-2032)
1.3.8 India Based Company Drugs for Malaria Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Malaria Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Drugs for Malaria Consumption Value (2021-2032)
2.2 World Drugs for Malaria Consumption Value by Region
2.2.1 World Drugs for Malaria Consumption Value by Region (2021-2026)
2.2.2 World Drugs for Malaria Consumption Value Forecast by Region (2027-2032)
2.3 United States Drugs for Malaria Consumption Value (2021-2032)
2.4 China Drugs for Malaria Consumption Value (2021-2032)
2.5 Europe Drugs for Malaria Consumption Value (2021-2032)
2.6 Japan Drugs for Malaria Consumption Value (2021-2032)
2.7 South Korea Drugs for Malaria Consumption Value (2021-2032)
2.8 ASEAN Drugs for Malaria Consumption Value (2021-2032)
2.9 India Drugs for Malaria Consumption Value (2021-2032)
3 WORLD DRUGS FOR MALARIA COMPANIES COMPETITIVE ANALYSIS
3.1 World Drugs for Malaria Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drugs for Malaria Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drugs for Malaria in 2025
3.2.3 Global Concentration Ratios (CR8) for Drugs for Malaria in 2025
3.3 Drugs for Malaria Company Evaluation Quadrant
3.4 Drugs for Malaria Market: Overall Company Footprint Analysis
3.4.1 Drugs for Malaria Market: Region Footprint
3.4.2 Drugs for Malaria Market: Company Product Type Footprint
3.4.3 Drugs for Malaria Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drugs for Malaria Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drugs for Malaria Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Drugs for Malaria Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Drugs for Malaria Consumption Value Comparison
4.2.1 United States VS China: Drugs for Malaria Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drugs for Malaria Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Drugs for Malaria Companies and Market Share, 2021-2026
4.3.1 United States Based Drugs for Malaria Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drugs for Malaria Revenue, (2021-2026)
4.4 China Based Companies Drugs for Malaria Revenue and Market Share, 2021-2026
4.4.1 China Based Drugs for Malaria Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drugs for Malaria Revenue, (2021-2026)
4.5 Rest of World Based Drugs for Malaria Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Drugs for Malaria Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Drugs for Malaria Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs for Malaria Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Aryl Aminoalcohol Compounds
5.2.2 Antifolate Compounds
5.2.3 Artemisinin Compounds
5.3 Market Segment by Type
5.3.1 World Drugs for Malaria Market Size by Type (2021-2026)
5.3.2 World Drugs for Malaria Market Size by Type (2027-2032)
5.3.3 World Drugs for Malaria Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drugs for Malaria Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Prevention
6.2.2 Treatment
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Drugs for Malaria Market Size by Application (2021-2026)
6.3.2 World Drugs for Malaria Market Size by Application (2027-2032)
6.3.3 World Drugs for Malaria Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Cipla
7.1.1 Cipla Details
7.1.2 Cipla Major Business
7.1.3 Cipla Drugs for Malaria Product and Services
7.1.4 Cipla Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Cipla Recent Developments/Updates
7.1.6 Cipla Competitive Strengths & Weaknesses
7.2 Guilin Pharmaceutical
7.2.1 Guilin Pharmaceutical Details
7.2.2 Guilin Pharmaceutical Major Business
7.2.3 Guilin Pharmaceutical Drugs for Malaria Product and Services
7.2.4 Guilin Pharmaceutical Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Guilin Pharmaceutical Recent Developments/Updates
7.2.6 Guilin Pharmaceutical Competitive Strengths & Weaknesses
7.3 IPCA Laboratories
7.3.1 IPCA Laboratories Details
7.3.2 IPCA Laboratories Major Business
7.3.3 IPCA Laboratories Drugs for Malaria Product and Services
7.3.4 IPCA Laboratories Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 IPCA Laboratories Recent Developments/Updates
7.3.6 IPCA Laboratories Competitive Strengths & Weaknesses
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Details
7.4.2 GlaxoSmithKline Major Business
7.4.3 GlaxoSmithKline Drugs for Malaria Product and Services
7.4.4 GlaxoSmithKline Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 GlaxoSmithKline Recent Developments/Updates
7.4.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.5 Mylan Labs
7.5.1 Mylan Labs Details
7.5.2 Mylan Labs Major Business
7.5.3 Mylan Labs Drugs for Malaria Product and Services
7.5.4 Mylan Labs Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Mylan Labs Recent Developments/Updates
7.5.6 Mylan Labs Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche Drugs for Malaria Product and Services
7.6.4 Roche Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis Drugs for Malaria Product and Services
7.7.4 Novartis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 Sanofi Aventis
7.8.1 Sanofi Aventis Details
7.8.2 Sanofi Aventis Major Business
7.8.3 Sanofi Aventis Drugs for Malaria Product and Services
7.8.4 Sanofi Aventis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Sanofi Aventis Recent Developments/Updates
7.8.6 Sanofi Aventis Competitive Strengths & Weaknesses
7.9 Ajanta Pharma
7.9.1 Ajanta Pharma Details
7.9.2 Ajanta Pharma Major Business
7.9.3 Ajanta Pharma Drugs for Malaria Product and Services
7.9.4 Ajanta Pharma Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Ajanta Pharma Recent Developments/Updates
7.9.6 Ajanta Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Drugs for Malaria Industry Chain
8.2 Drugs for Malaria Upstream Analysis
8.3 Drugs for Malaria Midstream Analysis
8.4 Drugs for Malaria Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Drugs for Malaria Introduction
1.2 World Drugs for Malaria Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Drugs for Malaria Total Market by Region (by Headquarter Location)
1.3.1 World Drugs for Malaria Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Drugs for Malaria Revenue (2021-2032)
1.3.3 China Based Company Drugs for Malaria Revenue (2021-2032)
1.3.4 Europe Based Company Drugs for Malaria Revenue (2021-2032)
1.3.5 Japan Based Company Drugs for Malaria Revenue (2021-2032)
1.3.6 South Korea Based Company Drugs for Malaria Revenue (2021-2032)
1.3.7 ASEAN Based Company Drugs for Malaria Revenue (2021-2032)
1.3.8 India Based Company Drugs for Malaria Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Malaria Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Drugs for Malaria Consumption Value (2021-2032)
2.2 World Drugs for Malaria Consumption Value by Region
2.2.1 World Drugs for Malaria Consumption Value by Region (2021-2026)
2.2.2 World Drugs for Malaria Consumption Value Forecast by Region (2027-2032)
2.3 United States Drugs for Malaria Consumption Value (2021-2032)
2.4 China Drugs for Malaria Consumption Value (2021-2032)
2.5 Europe Drugs for Malaria Consumption Value (2021-2032)
2.6 Japan Drugs for Malaria Consumption Value (2021-2032)
2.7 South Korea Drugs for Malaria Consumption Value (2021-2032)
2.8 ASEAN Drugs for Malaria Consumption Value (2021-2032)
2.9 India Drugs for Malaria Consumption Value (2021-2032)
3 WORLD DRUGS FOR MALARIA COMPANIES COMPETITIVE ANALYSIS
3.1 World Drugs for Malaria Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drugs for Malaria Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drugs for Malaria in 2025
3.2.3 Global Concentration Ratios (CR8) for Drugs for Malaria in 2025
3.3 Drugs for Malaria Company Evaluation Quadrant
3.4 Drugs for Malaria Market: Overall Company Footprint Analysis
3.4.1 Drugs for Malaria Market: Region Footprint
3.4.2 Drugs for Malaria Market: Company Product Type Footprint
3.4.3 Drugs for Malaria Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drugs for Malaria Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drugs for Malaria Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Drugs for Malaria Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Drugs for Malaria Consumption Value Comparison
4.2.1 United States VS China: Drugs for Malaria Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drugs for Malaria Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Drugs for Malaria Companies and Market Share, 2021-2026
4.3.1 United States Based Drugs for Malaria Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drugs for Malaria Revenue, (2021-2026)
4.4 China Based Companies Drugs for Malaria Revenue and Market Share, 2021-2026
4.4.1 China Based Drugs for Malaria Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drugs for Malaria Revenue, (2021-2026)
4.5 Rest of World Based Drugs for Malaria Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Drugs for Malaria Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Drugs for Malaria Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs for Malaria Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Aryl Aminoalcohol Compounds
5.2.2 Antifolate Compounds
5.2.3 Artemisinin Compounds
5.3 Market Segment by Type
5.3.1 World Drugs for Malaria Market Size by Type (2021-2026)
5.3.2 World Drugs for Malaria Market Size by Type (2027-2032)
5.3.3 World Drugs for Malaria Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drugs for Malaria Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Prevention
6.2.2 Treatment
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Drugs for Malaria Market Size by Application (2021-2026)
6.3.2 World Drugs for Malaria Market Size by Application (2027-2032)
6.3.3 World Drugs for Malaria Market Size Market Share by Application (2021-2032)
7 COMPANY PROFILES
7.1 Cipla
7.1.1 Cipla Details
7.1.2 Cipla Major Business
7.1.3 Cipla Drugs for Malaria Product and Services
7.1.4 Cipla Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Cipla Recent Developments/Updates
7.1.6 Cipla Competitive Strengths & Weaknesses
7.2 Guilin Pharmaceutical
7.2.1 Guilin Pharmaceutical Details
7.2.2 Guilin Pharmaceutical Major Business
7.2.3 Guilin Pharmaceutical Drugs for Malaria Product and Services
7.2.4 Guilin Pharmaceutical Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 Guilin Pharmaceutical Recent Developments/Updates
7.2.6 Guilin Pharmaceutical Competitive Strengths & Weaknesses
7.3 IPCA Laboratories
7.3.1 IPCA Laboratories Details
7.3.2 IPCA Laboratories Major Business
7.3.3 IPCA Laboratories Drugs for Malaria Product and Services
7.3.4 IPCA Laboratories Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 IPCA Laboratories Recent Developments/Updates
7.3.6 IPCA Laboratories Competitive Strengths & Weaknesses
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Details
7.4.2 GlaxoSmithKline Major Business
7.4.3 GlaxoSmithKline Drugs for Malaria Product and Services
7.4.4 GlaxoSmithKline Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 GlaxoSmithKline Recent Developments/Updates
7.4.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.5 Mylan Labs
7.5.1 Mylan Labs Details
7.5.2 Mylan Labs Major Business
7.5.3 Mylan Labs Drugs for Malaria Product and Services
7.5.4 Mylan Labs Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Mylan Labs Recent Developments/Updates
7.5.6 Mylan Labs Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche Drugs for Malaria Product and Services
7.6.4 Roche Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
7.7 Novartis
7.7.1 Novartis Details
7.7.2 Novartis Major Business
7.7.3 Novartis Drugs for Malaria Product and Services
7.7.4 Novartis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Novartis Recent Developments/Updates
7.7.6 Novartis Competitive Strengths & Weaknesses
7.8 Sanofi Aventis
7.8.1 Sanofi Aventis Details
7.8.2 Sanofi Aventis Major Business
7.8.3 Sanofi Aventis Drugs for Malaria Product and Services
7.8.4 Sanofi Aventis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Sanofi Aventis Recent Developments/Updates
7.8.6 Sanofi Aventis Competitive Strengths & Weaknesses
7.9 Ajanta Pharma
7.9.1 Ajanta Pharma Details
7.9.2 Ajanta Pharma Major Business
7.9.3 Ajanta Pharma Drugs for Malaria Product and Services
7.9.4 Ajanta Pharma Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Ajanta Pharma Recent Developments/Updates
7.9.6 Ajanta Pharma Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Drugs for Malaria Industry Chain
8.2 Drugs for Malaria Upstream Analysis
8.3 Drugs for Malaria Midstream Analysis
8.4 Drugs for Malaria Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Drugs for Malaria Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Drugs for Malaria Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Drugs for Malaria Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Drugs for Malaria Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Drugs for Malaria Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drugs for Malaria Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Drugs for Malaria Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Drugs for Malaria Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Drugs for Malaria Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Drugs for Malaria Players in 2025
Table 12. World Drugs for Malaria Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Drugs for Malaria Company Evaluation Quadrant
Table 14. Head Office of Key Drugs for Malaria Players
Table 15. Drugs for Malaria Market: Company Product Type Footprint
Table 16. Drugs for Malaria Market: Company Product Application Footprint
Table 17. Drugs for Malaria Mergers & Acquisitions Activity
Table 18. United States VS China Drugs for Malaria Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Drugs for Malaria Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Drugs for Malaria Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drugs for Malaria Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Drugs for Malaria Revenue Market Share (2021-2026)
Table 23. China Based Drugs for Malaria Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drugs for Malaria Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Drugs for Malaria Revenue Market Share (2021-2026)
Table 26. Rest of World Based Drugs for Malaria Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Drugs for Malaria Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Drugs for Malaria Revenue Market Share (2021-2026)
Table 29. World Drugs for Malaria Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Drugs for Malaria Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Drugs for Malaria Market Size by Type (2027-2032) & (USD Million)
Table 32. World Drugs for Malaria Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Drugs for Malaria Market Size by Application (2021-2026) & (USD Million)
Table 34. World Drugs for Malaria Market Size by Application (2027-2032) & (USD Million)
Table 35. Cipla Basic Information, Manufacturing Base and Competitors
Table 36. Cipla Major Business
Table 37. Cipla Drugs for Malaria Product and Services
Table 38. Cipla Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Cipla Recent Developments/Updates
Table 40. Cipla Competitive Strengths & Weaknesses
Table 41. Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 42. Guilin Pharmaceutical Major Business
Table 43. Guilin Pharmaceutical Drugs for Malaria Product and Services
Table 44. Guilin Pharmaceutical Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Guilin Pharmaceutical Recent Developments/Updates
Table 46. Guilin Pharmaceutical Competitive Strengths & Weaknesses
Table 47. IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. IPCA Laboratories Major Business
Table 49. IPCA Laboratories Drugs for Malaria Product and Services
Table 50. IPCA Laboratories Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. IPCA Laboratories Recent Developments/Updates
Table 52. IPCA Laboratories Competitive Strengths & Weaknesses
Table 53. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 54. GlaxoSmithKline Major Business
Table 55. GlaxoSmithKline Drugs for Malaria Product and Services
Table 56. GlaxoSmithKline Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 59. Mylan Labs Basic Information, Manufacturing Base and Competitors
Table 60. Mylan Labs Major Business
Table 61. Mylan Labs Drugs for Malaria Product and Services
Table 62. Mylan Labs Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Mylan Labs Recent Developments/Updates
Table 64. Mylan Labs Competitive Strengths & Weaknesses
Table 65. Roche Basic Information, Manufacturing Base and Competitors
Table 66. Roche Major Business
Table 67. Roche Drugs for Malaria Product and Services
Table 68. Roche Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Roche Recent Developments/Updates
Table 70. Roche Competitive Strengths & Weaknesses
Table 71. Novartis Basic Information, Manufacturing Base and Competitors
Table 72. Novartis Major Business
Table 73. Novartis Drugs for Malaria Product and Services
Table 74. Novartis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Novartis Recent Developments/Updates
Table 76. Novartis Competitive Strengths & Weaknesses
Table 77. Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table 78. Sanofi Aventis Major Business
Table 79. Sanofi Aventis Drugs for Malaria Product and Services
Table 80. Sanofi Aventis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sanofi Aventis Recent Developments/Updates
Table 82. Sanofi Aventis Competitive Strengths & Weaknesses
Table 83. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Ajanta Pharma Major Business
Table 85. Ajanta Pharma Drugs for Malaria Product and Services
Table 86. Ajanta Pharma Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Ajanta Pharma Recent Developments/Updates
Table 88. Ajanta Pharma Competitive Strengths & Weaknesses
Table 89. Global Key Players of Drugs for Malaria Upstream (Raw Materials)
Table 90. Global Drugs for Malaria Typical Customers
Table 1. World Drugs for Malaria Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Drugs for Malaria Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Drugs for Malaria Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Drugs for Malaria Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Drugs for Malaria Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drugs for Malaria Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Drugs for Malaria Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Drugs for Malaria Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Drugs for Malaria Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Drugs for Malaria Players in 2025
Table 12. World Drugs for Malaria Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Drugs for Malaria Company Evaluation Quadrant
Table 14. Head Office of Key Drugs for Malaria Players
Table 15. Drugs for Malaria Market: Company Product Type Footprint
Table 16. Drugs for Malaria Market: Company Product Application Footprint
Table 17. Drugs for Malaria Mergers & Acquisitions Activity
Table 18. United States VS China Drugs for Malaria Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Drugs for Malaria Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Drugs for Malaria Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drugs for Malaria Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Drugs for Malaria Revenue Market Share (2021-2026)
Table 23. China Based Drugs for Malaria Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drugs for Malaria Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Drugs for Malaria Revenue Market Share (2021-2026)
Table 26. Rest of World Based Drugs for Malaria Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Drugs for Malaria Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Drugs for Malaria Revenue Market Share (2021-2026)
Table 29. World Drugs for Malaria Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Drugs for Malaria Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Drugs for Malaria Market Size by Type (2027-2032) & (USD Million)
Table 32. World Drugs for Malaria Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 33. World Drugs for Malaria Market Size by Application (2021-2026) & (USD Million)
Table 34. World Drugs for Malaria Market Size by Application (2027-2032) & (USD Million)
Table 35. Cipla Basic Information, Manufacturing Base and Competitors
Table 36. Cipla Major Business
Table 37. Cipla Drugs for Malaria Product and Services
Table 38. Cipla Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Cipla Recent Developments/Updates
Table 40. Cipla Competitive Strengths & Weaknesses
Table 41. Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 42. Guilin Pharmaceutical Major Business
Table 43. Guilin Pharmaceutical Drugs for Malaria Product and Services
Table 44. Guilin Pharmaceutical Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Guilin Pharmaceutical Recent Developments/Updates
Table 46. Guilin Pharmaceutical Competitive Strengths & Weaknesses
Table 47. IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table 48. IPCA Laboratories Major Business
Table 49. IPCA Laboratories Drugs for Malaria Product and Services
Table 50. IPCA Laboratories Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. IPCA Laboratories Recent Developments/Updates
Table 52. IPCA Laboratories Competitive Strengths & Weaknesses
Table 53. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 54. GlaxoSmithKline Major Business
Table 55. GlaxoSmithKline Drugs for Malaria Product and Services
Table 56. GlaxoSmithKline Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. GlaxoSmithKline Recent Developments/Updates
Table 58. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 59. Mylan Labs Basic Information, Manufacturing Base and Competitors
Table 60. Mylan Labs Major Business
Table 61. Mylan Labs Drugs for Malaria Product and Services
Table 62. Mylan Labs Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Mylan Labs Recent Developments/Updates
Table 64. Mylan Labs Competitive Strengths & Weaknesses
Table 65. Roche Basic Information, Manufacturing Base and Competitors
Table 66. Roche Major Business
Table 67. Roche Drugs for Malaria Product and Services
Table 68. Roche Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Roche Recent Developments/Updates
Table 70. Roche Competitive Strengths & Weaknesses
Table 71. Novartis Basic Information, Manufacturing Base and Competitors
Table 72. Novartis Major Business
Table 73. Novartis Drugs for Malaria Product and Services
Table 74. Novartis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Novartis Recent Developments/Updates
Table 76. Novartis Competitive Strengths & Weaknesses
Table 77. Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table 78. Sanofi Aventis Major Business
Table 79. Sanofi Aventis Drugs for Malaria Product and Services
Table 80. Sanofi Aventis Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Sanofi Aventis Recent Developments/Updates
Table 82. Sanofi Aventis Competitive Strengths & Weaknesses
Table 83. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Ajanta Pharma Major Business
Table 85. Ajanta Pharma Drugs for Malaria Product and Services
Table 86. Ajanta Pharma Drugs for Malaria Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Ajanta Pharma Recent Developments/Updates
Table 88. Ajanta Pharma Competitive Strengths & Weaknesses
Table 89. Global Key Players of Drugs for Malaria Upstream (Raw Materials)
Table 90. Global Drugs for Malaria Typical Customers
LIST OF FIGURES
Figure 1. Drugs for Malaria Picture
Figure 2. World Drugs for Malaria Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drugs for Malaria Total Revenue (2021-2032) & (USD Million)
Figure 4. World Drugs for Malaria Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Drugs for Malaria Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 13. Drugs for Malaria Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 16. World Drugs for Malaria Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 18. China Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 23. India Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Drugs for Malaria by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drugs for Malaria Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drugs for Malaria Markets in 2025
Figure 27. United States VS China: Drugs for Malaria Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Drugs for Malaria Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Drugs for Malaria Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Drugs for Malaria Market Size Market Share by Type in 2025
Figure 31. Aryl Aminoalcohol Compounds
Figure 32. Antifolate Compounds
Figure 33. Artemisinin Compounds
Figure 34. World Drugs for Malaria Market Size Market Share by Type (2021-2032)
Figure 35. World Drugs for Malaria Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Drugs for Malaria Market Size Market Share by Application in 2025
Figure 37. Prevention
Figure 38. Treatment
Figure 39. Others
Figure 40. World Drugs for Malaria Market Size Market Share by Application (2021-2032)
Figure 41. Drugs for Malaria Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Drugs for Malaria Picture
Figure 2. World Drugs for Malaria Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drugs for Malaria Total Revenue (2021-2032) & (USD Million)
Figure 4. World Drugs for Malaria Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Drugs for Malaria Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Drugs for Malaria Revenue (2021-2032) & (USD Million)
Figure 13. Drugs for Malaria Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 16. World Drugs for Malaria Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 18. China Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 23. India Drugs for Malaria Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Drugs for Malaria by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drugs for Malaria Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drugs for Malaria Markets in 2025
Figure 27. United States VS China: Drugs for Malaria Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Drugs for Malaria Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Drugs for Malaria Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Drugs for Malaria Market Size Market Share by Type in 2025
Figure 31. Aryl Aminoalcohol Compounds
Figure 32. Antifolate Compounds
Figure 33. Artemisinin Compounds
Figure 34. World Drugs for Malaria Market Size Market Share by Type (2021-2032)
Figure 35. World Drugs for Malaria Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 36. World Drugs for Malaria Market Size Market Share by Application in 2025
Figure 37. Prevention
Figure 38. Treatment
Figure 39. Others
Figure 40. World Drugs for Malaria Market Size Market Share by Application (2021-2032)
Figure 41. Drugs for Malaria Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
